Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

The Motley Fool June 28, 2011 Eric Bleeker	Johnson & Johnson Is Looking Abroad for Growth Where's Johnson & Johnson generating its sales?
The Motley Fool October 27, 2011 Eric Bleeker	Here's Where Agilent's Finding Its Growth Four years ago, Agilent produced 34% of its sales within the United States.
The Motley Fool October 27, 2011 Eric Bleeker	Where Is Honeywell Finding Its Growth? Where's your company generating its sales? Here's where Honeywell's sales and earnings come from and how its sales abroad have changed over time.
The Motley Fool October 27, 2011 Eric Bleeker	Here's Where 3M's Finding Its Growth Where's your company generating its sales? Here's a look at where 3M's sales and earnings come from and how its sales abroad have changed over time.
The Motley Fool October 31, 2011 Eric Bleeker	Where Automatic Data Processing Is Finding Its Growth Five years ago, ADP collected 83% of its sales from the United States.
The Motley Fool October 31, 2011 Eric Bleeker	Where Under Armour Is Finding Its Growth Five years ago, Under Armour collected 98% of its sales from the United States and Canada. At the time, sales to other countries totaled just $5.5 million.
The Motley Fool October 31, 2011 Eric Bleeker	Where Amgen Is Finding Its Growth Five years ago, Amgen collected 83% of its sales from the United States.
The Motley Fool October 29, 2011 Eric Bleeker	Can Overseas Sales Drive Autodesk Forward? Four years ago, 37% of sales went to the EMEA (Europe, Middle East, and Africa) region, but the United States wasn't far behind at 34%.
The Motley Fool June 27, 2011 Eric Bleeker	Can Google Conquer the World? Where's Google generating its sales?
The Motley Fool October 29, 2011 Eric Bleeker	Can International Opportunities Drive salesforce.com Forward? salesforce.com is managing to make inroads around the world. While other software peers have difficulty profiting in emerging markets where piracy runs rampant, salesforce.com's cloud focus will help it mitigate this threat.
The Motley Fool October 30, 2011 Eric Bleeker	Can India Drive American Tower's Growth? Today, 81% of American Tower's assets are still held in the United States, but it's rapidly expanding internationally.
The Motley Fool October 24, 2011 Eric Bleeker	Here's What Is Fueling PepsiCo's Growth While PepsiCo has been steadily growing its international sales, it has a long way to go before it reaches the same level as Coca-Cola or Kraft.
The Motley Fool October 31, 2011 Eric Bleeker	Where F5 Networks Is Finding Its Growth Four years ago, F5 Networks collected 83% of its sales from the Americas.
The Motley Fool June 27, 2011 Eric Bleeker	Here's What Drives Coca-Cola's International Cash Machine Let's look at where Coca-Cola's sales and earnings come from, and how its sales abroad have changed over time.
The Motley Fool June 28, 2011 Eric Bleeker	Can Adobe Cash in on Booming Growth Abroad? Where's Adobe generating its sales?
The Motley Fool October 29, 2011 Eric Bleeker	Where Can Nokia Still Find Growth? Today, you see the rapid shift in Nokia's business to emerging markets where, cheaper phones are far more popular.
The Motley Fool June 27, 2011 Eric Bleeker	What's Driving IBM's Profits Forward? Where's IBM generating its sales?
The Motley Fool October 30, 2011 Eric Bleeker	Can Akamai Find Foreign Growth? Five years ago, Akamai collected 63% of its sales from the United States.
The Motley Fool October 19, 2009 Brian Orelli	Foolish Forecast: A Last Look at "Mini" Pfizer In advance of Pfizer's last earnings report before their acquisition of Wyeth, analysts expect a drop in sales and a bigger bottom line decrease.
The Motley Fool October 24, 2011 Eric Bleeker	Where Is Deere Finding Its Growth? Deere is carefully balancing milking its cash cow while working to aggressively expand its presence in International markets at the expense of lower margins.
The Motley Fool October 31, 2011 Eric Bleeker	Where BMC Is Finding Its Growth BMC's ability to profit from other geographies has been a key advantage for the company, but could also pose a challenge in coming quarters.
The Motley Fool July 30, 2011 Eric Bleeker	Where Is GE's Growth Coming From? We'll examine not only where its sales and earnings come from, but also how its sales abroad have changed over time.
The Motley Fool June 29, 2011 Eric Bleeker	Can Foreign Sales Keep Boeing Growing? Where's Boeing generating its sales?
The Motley Fool July 27, 2011 Eric Bleeker	Caterpillar: Can China Change Its Fortune? Where does Caterpillar's sales and earnings come from, and how has its sales abroad have changed over time.
The Motley Fool June 29, 2011 Eric Bleeker	Procter & Gamble: Assessing the International Opportunity Where's Procter & Gamble generating its sales?
The Motley Fool October 30, 2009 Brian Orelli	World's Scariest Stocks: Pfizer For Pfizer, the big, scary unknown comes from whether it can integrate its recent acquisition of Wyeth.
The Motley Fool October 29, 2011 Eric Bleeker	Can Tibco Conquer the World? We'll examine not only where its sales and earnings come from, but also how its sales abroad have changed over time.
The Motley Fool August 17, 2011 Ilan Moscovitz	Pfizer Is Cheaper Than You Think Let's examine Pfizer alongside some of its peers for additional context.
The Motley Fool December 18, 2008 Brian Orelli	Best Stock for 2009: Pfizer Pfizer's languishing stock price has made the company so much more attractive; it could see a breakout in 2009.
The Motley Fool October 24, 2011 Eric Bleeker	McDonald's: Looking at the International Opportunity The more you dig into McDonald's sales, the more you realize the international change the company is undergoing.
The Motley Fool February 24, 2009 Brian Orelli	Pfizer: Diversified Dreams, Dubious Decisions Pfizer's CEO Jeffrey Kindler said he wants to make his company more like Johnson & Johnson and Abbott Labs, which aren't dependent on one product for success.
The Motley Fool July 21, 2009 Brian Orelli	Foolish Forecast: Pfizer Meanders Toward Merger Let's look at what to expect when the pharmaceutical giant releases earnings tomorrow.
The Motley Fool July 8, 2011 Brian Orelli	Half a Breakup Is Better Than No Breakup at All Pfizer keeps two divisions and puts two on the chopping block.
The Motley Fool May 4, 2010 Brian Orelli	Earnings Growth Trumps Revenue Growth, Except Here A solid quarter for Pfizer, but is there more in the tank?
The Motley Fool December 7, 2010 Brian Orelli	How Pfizer's New Chief Can Right the Ship Bigger is not always better.
The Motley Fool September 2, 2010 Anand Chokkavelu	Is Pfizer Stock Cheap Right Now? If you find Pfizer's numbers compelling, continue your due diligence.
The Motley Fool June 29, 2011 Eric Bleeker	Can Foreign Sales Keep Oracle Growing? Where's Oracle generating its sales?
The Motley Fool September 3, 2009 Brian Orelli	Now That's How to Grow a Company! Dear Pfizer and Merck, you really should take note of how Abbott Labs is growing.
The Motley Fool September 30, 2009 Brian Orelli	Bigger Size, Lower Returns History is not on Merck and Schering's side.
The Motley Fool June 27, 2011 Eric Bleeker	Apple's Overseas Demand in a Word: Exploding Where's Apple generating its sales?
The Motley Fool June 15, 2010 Brian Orelli	Pfizer Focuses, Investors Should Cheer The culling of the pipeline continues at Pfizer. While that's bad news for partners that signed on with the company or with Wyeth before the merger it's a good move for Pfizer.
The Motley Fool March 18, 2009 Brian Orelli	Merck Pummels Pfizer One of these acquisitions is not like the other.
The Motley Fool October 27, 2009 Brian Orelli	Pfizer's and Merck's Loss Is These Companies' Gain Are Pfizer and Merck too busy integrating now to take advantage of additional acquisitions?
The Motley Fool February 3, 2010 Brian Orelli	Wyeth Can't Save Pfizer Not much earnings growth, but the price is right.
The Motley Fool October 24, 2011	A Brief History of Pfizer's Returns At 14 times earnings, Pfizer looks reasonably valued, but not exactly cheap.
The Motley Fool October 30, 2011 Eric Bleeker	Can Amazon.com Conquer the World? Five years ago, Amazon collected 55% of its sales from the United States, while foreign markets kicked in remaining 45%.
The Motley Fool January 28, 2009 Brian Orelli	A Mini-Pfizer in the Making Bristol-Myers Squibb looks like its setting itself up to be the next Pfizer.
The Motley Fool August 12, 2010 Brian Orelli	Pfizer: Strengths, Weaknesses, Opportunities, Threats Knowing them all makes it easier to judge an investment.
The Motley Fool March 24, 2009 Robert Steyer	Drugmakers Diversify -- Again Merck and Pfizer choose businesses they once eschewed.
Chemistry World February 12, 2015 Rebecca Trager	Hospira buyout is a shot in the arm for Pfizer's biosimilars Pfizer said in a statement that its acquisition of Hospira will create 'a leading global sterile injectables business.